A recent study expands the phenotypic spectrum of FGF12-related epilepsy, suggesting that precision therapy may influence patient outcomes. This research highlights the need for tailored treatment approaches in managing this rare form of epilepsy.
expanding the phenotypic spectrum of fgf12 epilepsy does prompt precision therapy affect outcomes
Original title: “Expanding the phenotypic spectrum of FGF12-epilepsy-does prompt precision therapy affect outcomes?”